新的和正在开发的第一线药物疗法用于治疗非霍奇金淋巴瘤
Bruce Hough1,2, Olga Lytvynova3, Ariel Sindel3,4
1Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, USA.
Expert opinion on pharmacotherapy
|August 17, 2024
概括
本综述涵盖了非霍奇金淋巴瘤 (NHL) 的新一线治疗方法,包括针对性疗法和免疫疗法,基于最近的分类和分子见解.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 非霍奇金淋巴瘤 (NHL) 代表了一组多样化的淋巴细胞恶性瘤.
- 了解淋巴发育的近期进展刺激了新型治疗剂的开发.
- 2022年将推出两个主要分类:世卫组织第五版和ICC.
研究的目的:
- 审查NHL的新兴一线药物治疗方法.
- 根据作用机制对治疗进行排列,并强调关键的临床试验.
- 讨论NHL治疗中的挑战和未来战略.
主要方法:
- 最近临床试验和治疗发展的文献综述.
- 对新型向疗法和免疫疗法的分析.
- 讨论治疗耐药性,测序策略和成本效益.
主要成果:
- 对淋巴瘤的治愈性组合化疗的概述.
- 探索针对性治疗的耐药性机制,包括布鲁顿氨酸激酶抑制剂.
- 对T细胞疗法测序和财务毒性的检查.
结论:
- 新型药物的开发为NHL治疗提供了新的希望.
- 解决治疗耐药性和优化治疗顺序至关重要.
- 需要制定改善治愈率,降低毒性和提高全球卫生公平性的战略.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
Cancer Vaccines
347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
Drug Therapy
41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
41
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


